Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Levocetirizine

1 tablet of Levocetirizine 5 mg OD in the morning for 29+/-4 days

DRUG

Placebo

1 placebo tablet OD in the morning for 29+/-4 days

Trial Locations (1)

404597

Institut für Atemwegsforschung GmbH, Düsseldorf

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Institut für Atemwegsforschung GmbH

INDUSTRY

NCT00439712 - Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter